Skip to main content
TCRT
NASDAQ Life Sciences

Alaunos Therapeutics Reports $0 Revenue, Wider Q1 Loss; Future Contingent on Financing

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.47
Mkt Cap
$5.934M
52W Low
$1.67
52W High
$6.2
52W Position info
48% above low
Off High info
60% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TCRT sits 48% above its 52-week low of $1.67.

Summary

Alaunos Therapeutics reported its first-quarter 2026 results, showing no revenue and a wider net loss of $1.155 million compared to the prior year. While diluted EPS improved slightly to $(0.59), the company's financial position remains challenging with zero revenue. The report highlighted preclinical progress for its lead small-molecule program, ALN1003, with positive proof-of-concept data. Critically, the company stated that advancement of its IND-enabling work is contingent on securing strategic financing or collaborations, signaling a significant funding risk and potential for future dilution for this micro-cap biotech.

At the time of this announcement, TCRT was trading at $2.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.9M. The 52-week trading range was $1.67 to $6.20. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TCRT - Latest Insights

TCRT
Oct 23, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $1.75 info
Change: -$0.6987 (-29%) info
Market Cap: $6.326M info
TCRT
Oct 21, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $1.75 info
Change: -$1.40 (-44%) info
Market Cap: $6.326M info
TCRT
Oct 15, 2026, 7:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.75 info
Change: -$1.13 (-39%) info
Market Cap: $6.326M info
TCRT
Oct 15, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.75 info
Change: -$0.4287 (-20%) info
Market Cap: $6.326M info
TCRT
Oct 13, 2026, 2:23 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.95
Real-time Price: $1.75 info
Change: -$1.20 (-41%) info
Market Cap: $6.326M info